UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B: a clue from serum HBsAg levels

Antiviral therapy, 2007, Vol.12 (1), p.73-82

2007

Volltextzugriff (PDF)

Coexpression Network Analysis-Based Identification of Critical Genes Differentiating between Latent and Active Tuberculosis

Disease markers, 2022-11, Vol.2022, p.1-11

2022

Volltextzugriff (PDF)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma

Disease markers, 2019, Vol.2019 (2019), p.1-6

2019

Volltextzugriff (PDF)

Increased Serum Levels of sCD206 Are Associated with Adverse Prognosis in Patients with HBV-Related Decompensated Cirrhosis

Disease markers, 2022-05, Vol.2022, p.7881478-10

2022

Volltextzugriff (PDF)

Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

Disease markers, 2020, Vol.2020 (2020), p.1-11

2020

Volltextzugriff (PDF)

High Circulating Caspase-Cleaved Keratin 18 Fragments (M30) Indicate Short-Term Mortality in Critically Ill Patients

Disease markers, 2018-01, Vol.2018 (2018), p.1-8

2018

Volltextzugriff (PDF)

Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients”

Disease markers, 2019-01, Vol.2019 (2019), p.1-4

2019

Volltextzugriff (PDF)

Cytomegalovirus Cholangiopathy in an Immunocompetent Patient: A Case Report and Literature Review

Case reports in hepatology, 2021-11, Vol.2021, p.1-4

2021

Volltextzugriff (PDF)

Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients”

Disease markers, 2018-01, Vol.2018 (2018), p.1-2

2018

Volltextzugriff (PDF)

Clinical characteristics, spontaneous clearance and treatment outcome of acute hepatitis C: A single tertiary center experience

Saudi journal of gastroenterology, 2013-03, Vol.19 (2), p.81-85

2013

Volltextzugriff (PDF)

Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B

Journal of hepatology, 2011-07, Vol.55 (1), p.61-68

2011

Volltextzugriff (PDF)

Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial

The American journal of gastroenterology, 2002-08, Vol.97 (8), p.2063-2070

2002

Volltextzugriff (PDF)

Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring

Antiviral therapy, 2007-01, Vol.12 (3), p.381-388

2007

Volltextzugriff (PDF)

Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial

The American journal of gastroenterology, 2002, Vol.97 (8), p.2063-2070

2002

Volltextzugriff (PDF)

Melioidosis: A Rare Cause of Liver Abscess

Case Reports in Hepatology, 2016-01, Vol.2016 (2016), p.1-3

2016

Volltextzugriff (PDF)

Linoleic Acid Induced Acute Hepatitis: A Case Report and Review of the Literature

Case reports in hepatology, 2015-01, Vol.2015 (2015), p.1-3

2015

Volltextzugriff (PDF)

Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir

Gastroenterology (New York, N.Y. 1943), 2012-09, Vol.143 (3), p.629-636.e1

2012

Volltextzugriff (PDF)

Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B

Expert review of gastroenterology & hepatology, 2020-04, Vol.14 (4), p.243-251

2020

Volltextzugriff (PDF)

Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B

Virology journal, 2022-01, Vol.19 (1), p.22-22, Article 22

2022

Volltextzugriff (PDF)

Viral Biomarkers in Chronic HBeAg Negative HBV Infection

Genes, 2018-09, Vol.9 (10), p.469

2018

Volltextzugriff (PDF)

The Natural Course of Chronic Hepatitis B Virus Infection and Its Management

Advances in Pharmacology, 2013, Vol.67, p.247-291

2013

Volltextzugriff (PDF)

Kinetics of quantitative hepatitis B surface antigen in patients with rheumatic disease and chronic hepatitis B receiving biologic agents

Journal of viral hepatitis, 2021-12, Vol.28 (12), p.1710-1718

2021

Volltextzugriff (PDF)

Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients

Arthritis research & therapy, 2021-03, Vol.23 (1), p.90-90, Article 90

2021

Volltextzugriff (PDF)

WED-406 DARING-B study: 5-year outcomes after nucleos (t)ide analogue (NA) cessation in Caucasian non-cirrhotic patients with HBeAg-negative chronic hepatitis B (CHBe-)

Journal of hepatology, 2024-06, Vol.80, p.S800-S800

2024

Volltextzugriff (PDF)

FRI-415 Hepatitis B virus genotype and some baseline characteristics, but not race, affect HBsAg kinetics during nucleos (t)ide analogue therapy

Journal of hepatology, 2024-06, Vol.80, p.S782-S782

2024

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(92)
Berichte
(1)

Sprache

Englisch
(93)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(68)
Science & Technology
(68)
Humans
(47)
Gastroenterology & Hepatology
(30)
Female
(26)
Male
(26)
Middle Aged
(25)
Infectious Diseases
(22)
Patients
(19)
Adult
(18)
Biological And Medical Sciences
(15)
Hepatitis
(15)
Aged
(14)
Virology
(14)
Antiviral Agents - Therapeutic Use
(13)
Hepatitis B
(13)
Medical Sciences
(13)
Hepatitis B, Chronic - Drug Therapy
(12)
Infections
(12)
Prospective Studies
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B: a clue from serum HBsAg levels

Coexpression Network Analysis-Based Identification of Critical Genes Differentiating between Latent and Active Tuberculosis

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma

Increased Serum Levels of sCD206 Are Associated with Adverse Prognosis in Patients with HBV-Related Decompensated Cirrhosis

Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

High Circulating Caspase-Cleaved Keratin 18 Fragments (M30) Indicate Short-Term Mortality in Critically Ill Patients

Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients”

Cytomegalovirus Cholangiopathy in an Immunocompetent Patient: A Case Report and Literature Review

Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients”

Clinical characteristics, spontaneous clearance and treatment outcome of acute hepatitis C: A single tertiary center experience

Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B

Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial

Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring

Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial

Melioidosis: A Rare Cause of Liver Abscess

Linoleic Acid Induced Acute Hepatitis: A Case Report and Review of the Literature

Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir

Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B

Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B

Viral Biomarkers in Chronic HBeAg Negative HBV Infection

The Natural Course of Chronic Hepatitis B Virus Infection and Its Management

Kinetics of quantitative hepatitis B surface antigen in patients with rheumatic disease and chronic hepatitis B receiving biologic agents

Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients

WED-406 DARING-B study: 5-year outcomes after nucleos (t)ide analogue (NA) cessation in Caucasian non-cirrhotic patients with HBeAg-negative chronic hepatitis B (CHBe-)

FRI-415 Hepatitis B virus genotype and some baseline characteristics, but not race, affect HBsAg kinetics during nucleos (t)ide analogue therapy

Suchergebnisse filtern